Holiferm Holiferm is a company that develops and offers licenses to its proprietary fermentation technology. | ![]() Vita 34 Vita 34 is the largest and the most experienced umbilical cord blood bank for medical precaution by means of stem cells in the German-speaking countries. | ||||
Founding Date | Founding Date 2018 | Founding Date 1997 | Founding Date 1990 | Founding Date 2000 | Founding Date 2006 |
Type | Type Private | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Manchester, GB HQ Daresbury, GB Wallasey, GB | Locations Leipzig, DE HQ Leipzig, DE | Locations Stockholm, SE HQ Hiroshima Shi, JP Minato Ku, JP Singapore, SG Lund, SE Doral, US | Locations Memphis, US HQ | Locations Palermo, IT HQ |
Employees | Employees 623% increase | Employees 771 | Employees 167 | Employees 1391% decrease | Employees 991% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 77.9 m | Valuation ($) 1 b | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €88.2m (FY, 2025) | Revenue (est.) kr1.5b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods €30m (FY, 2025) | Cost of goods kr391m (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit €59.8m (FY, 2025) | Gross profit kr1.1b (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income N/A | Net income (€5m) (FY, 2025) | Net income kr332.8m (FY, 2025) | Net income N/A | Net income N/A |

Vita 34 is the largest and the most experienced umbilical cord blood bank for medical precaution by means of stem cells in the German-speaking countries.
View company
BioGaia is a biotechnology company that develops and sells probiotic solutions.
View companyTransnetyx is a provider of biotechnology solutions.
View companyFondazione Ri.MED is a provider of biotechnology solutions.
View company